Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?

被引：1
|
作者：
Montoro-Garcia, Silvia [1 ,2 ]
Marin, Francisco [2 ]
Roldan, Vanessa [3 ]
Lip, Gregory Y. H. [1 ]
机构：
[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
[2] Hosp Univ Virgen de la Arrixaca, Dept Cardiol, Murcia, Spain
[3] Univ Murcia, Hosp Morales Meseguer, Dept Haematol, E-30001 Murcia, Spain
来源：
THROMBOSIS RESEARCH | 2011年 / 128卷 / 06期
关键词：
ATRIAL-FIBRILLATION; ATORVASTATIN; CARDIOVERSION; INFLAMMATION; RECURRENCE; STATINS; RISK;
D O I：
10.1016/j.thromres.2011.07.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：601 / 602
页数：2
相关论文
共 50 条
  • [21] Plasminogen activator inhibitor-1 (PAI-1) activity and retinal vascular calibre in type 2 diabetes
    Brazionis, L.
    Yau, J.
    Rowley, K.
    Itsiopoulos, C.
    O'Dea, K.
    Wong, T. Y.
    Jenkins, A.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (02) : 192 - 199
  • [22] Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients
    Kowal, Krzysztof
    Zukowski, Sebastian
    Moniuszko, Marcin
    Bodzenta-Lukaszyk, Anna
    [J]. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2008, 46 (02) : 193 - 198
  • [23] The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals
    Verschuur, M
    Jellema, A
    Bladbjerg, EM
    Feskens, EJM
    Mensink, RP
    Moller, L
    Vos, HL
    de Maat, MPM
    [J]. ATHEROSCLEROSIS, 2005, 181 (02) : 275 - 284
  • [24] Do plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator PAI-1 complexes (tPA-PAI-1) Predict complications in type 1 diabetes (TID)?
    Bosnyak, Z
    Forrest, KYZ
    Maser, RE
    Orchard, TJ
    [J]. DIABETES, 2001, 50 : A209 - A209
  • [25] THE CHARACTERIZATION OF A NOVEL INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN-VITRO
    FAINT, RW
    CHARLTON, P
    BENT, F
    BRYANS, J
    MACKIE, I
    BEVAN, P
    [J]. BLOOD, 1994, 84 (10) : A73 - A73
  • [26] Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
    Hélène Party
    Cléo Dujarrier
    Marie Hébert
    Sophie Lenoir
    Sara Martinez de Lizarrondo
    Raphaël Delépée
    Claudine Fauchon
    Marie-Christine Bouton
    Pauline Obiang
    Olivier Godefroy
    Etienne Save
    Laurent Lecardeur
    Joëlle Chabry
    Denis Vivien
    Véronique Agin
    [J]. Acta Neuropathologica Communications, 7
  • [27] GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) LOCUS
    DAWSON, S
    HAMSTEN, A
    WIMAN, B
    HENNEY, A
    HUMPHRIES, S
    [J]. FIBRINOLYSIS, 1990, 4 : 51 - 53
  • [28] MOLECULAR-FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN PLASMA
    ALESSI, MC
    JUHANVAGUE, I
    DECLERCK, PJ
    COLLEN, C
    [J]. THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 475 - 475
  • [29] Induction of conformational changes within crystals of plasminogen activator inhibitor-1 (PAI-1)
    Willems, PKA
    Gils, A
    Aertgeerts, K
    De Ranter, CJ
    Declerck, PJ
    [J]. FIBRINOLYSIS & PROTEOLYSIS, 1999, 13 (4-5): : 203 - 207
  • [30] ISOLATION AND CHARACTERIZATION OF REACTIVATED FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    DECLERCK, PJ
    DEMOL, M
    COLLEN, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 653 - 653
12345